Genome-wide target profiling of piggyBac and Tol2 in HEK 293: pros and cons for gene discovery and gene therapy
Authors
Meir, Yaa-Jyuhn JWeirauch, Matthew T
Yang, Herng-Shing
Chung, Pei-Cheng
Yu, Robert K.
Wu, Sareina C-Y
Issue Date
2011-03-30
Metadata
Show full item recordAbstract
Background: DNA transposons have emerged as indispensible tools for manipulating vertebrate genomes with applications ranging from insertional mutagenesis and transgenesis to gene therapy. To fully explore the potential of two highly active DNA transposons, piggyBac and Tol2, as mammalian genetic tools, we have conducted a side-by-side comparison of the two transposon systems in the same setting to evaluate their advantages and disadvantages for use in gene therapy and gene discovery.Results: We have observed that (1) the Tol2 transposase (but not piggyBac) is highly sensitive to molecular engineering; (2) the piggyBac donor with only the 40 bp 3'-and 67 bp 5'-terminal repeat domain is sufficient for effective transposition; and (3) a small amount of piggyBac transposases results in robust transposition suggesting the piggyBac transpospase is highly active. Performing genome-wide target profiling on data sets obtained by retrieving chromosomal targeting sequences from individual clones, we have identified several piggyBac and Tol2 hotspots and observed that (4) piggyBac and Tol2 display a clear difference in targeting preferences in the human genome. Finally, we have observed that (5) only sites with a particular sequence context can be targeted by either piggyBac or Tol2.
Conclusions: The non-overlapping targeting preference of piggyBac and Tol2 makes them complementary research tools for manipulating mammalian genomes. PiggyBac is the most promising transposon-based vector system for achieving site-specific targeting of therapeutic genes due to the flexibility of its transposase for being molecularly engineered. Insights from this study will provide a basis for engineering piggyBac transposases to achieve site-specific therapeutic gene targeting.
Citation
BMC Biotechnol. 2011 Mar 30; 11:28ae974a485f413a2113503eed53cd6c53
10.1186/1472-6750-11-28
Scopus Count
Related articles
- piggyBac is a flexible and highly active transposon as compared to sleeping beauty, Tol2, and Mos1 in mammalian cells.
- Authors: Wu SC, Meir YJ, Coates CJ, Handler AM, Pelczar P, Moisyadi S, Kaminski JM
- Issue date: 2006 Oct 10
- Comparative analysis of the recently discovered hAT transposon TcBuster in human cells.
- Authors: Woodard LE, Li X, Malani N, Kaja A, Hice RH, Atkinson PW, Bushman FD, Craig NL, Wilson MH
- Issue date: 2012
- A hyperactive piggyBac transposase for mammalian applications.
- Authors: Yusa K, Zhou L, Li MA, Bradley A, Craig NL
- Issue date: 2011 Jan 25
- Efficient transposition of the Tol2 transposable element from a single-copy donor in zebrafish.
- Authors: Urasaki A, Asakawa K, Kawakami K
- Issue date: 2008 Dec 16
- piggyBac transposase tools for genome engineering.
- Authors: Li X, Burnight ER, Cooney AL, Malani N, Brady T, Sander JD, Staber J, Wheelan SJ, Joung JK, McCray PB Jr, Bushman FD, Sinn PL, Craig NL
- Issue date: 2013 Jun 18